Skip to main content
Caplight Logo









curium pharma

curium pharma

Private

Last Round

Private Equity

Dec 2, 2020

Last Round Size

$1.43B

Est. Valuation

$3.57B

Total Funding Raised

$1.43B

Company Overview

The latest recorded funding round for curium pharma was a Private Equity round in December 2020. curium pharma has raised $1.43B.

Developer and manufacturer of radiopharmaceutical products for diagnosing and treating cancer, heart, brain, and bone diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

curium pharma Comparables

Compare curium pharma with similar companies based on industry and business-model similarity.

No comparables are published for curium pharma. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

curium pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityDec 2, 2020
DebtOct 13, 2020
M&AJan 27, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

curium pharma Filings

Explore SEC and related filing metadata, where available.

curium pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

Headquarters—
Year Founded2017
Last FundingDec 2, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?